This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Referenten: Roland Seckler, Vice President Global Supply Chain Operations, Ypsomed AG Heiko Schwarz, Geschäftsführer und Gründer, riskmethods GmbH
Moderation: Dr. Tobias Anslinger, BME e.V.
Referenten
Roland Seckler
Vice President Global Supply Chain OperationsYpsomed AG
Heiko Schwarz
Geschäftsführer & Gründerriskmethods GmbH
Dr. Tobias Anslinger
Chefredakteur BIPBME e.V.
Ypsomed
|
Our History
20042008
2009
201120172018
Strong growth in pen business for Sanofi Aventis until 2007Sanofi decides to also work with other suppliers in the future Ypsomed realigns itself Return to diabetes business with distribution of BGM systemsDevelopment of pen platform portfolio, since then investments of more than CHF 300 mio. in technology and more than CHF 200 mio. in market developmentBack to pump business with the distribution of Omnipod®
Introduction of the mylife™ YpsoPump® insulin pump systemFurther expansion of direct sales to more than 20 subsidiaries